LC-MS/MS ANALYSIS FOR PEPTIDES USING HUMAN BRADYKININ AND TWO OF ITS FRAGMENTS AS MODEL MOLECULES

被引:0
|
作者
Ion, Valentin [1 ]
Imre, Silvia [1 ]
Carje, Anca-Gabriela [1 ]
Balint, Alina [1 ]
Muntean, Daniela-Lucia [1 ]
机构
[1] Univ Med & & Pharm, Dept Analyt Chem & Drug Anal, Fac Pharm, 38 Gheorghe Marinescu St, Targu Mures 540139, Romania
关键词
LC-MS/MS; bradykinins; peptides; bioanalytical validation; LIQUID-CHROMATOGRAPHY; PROTEIN; QUANTIFICATION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptide analysis in the context of targeted or discovery proteomics applications assisted by liquid chromatography coupled with mass spectrometry gained increasingly more interest in the last ten years. In any of the proteomics applications cases, an efficient separation of the analysed peptides alongside the chromatographic column is foreseen. That is why this article aimed offer a better insight of peptide chromatographic and mass spectrometric behaviour. As model molecules, human bradykinin and two of its fragments, Bradykinin 1-8 and Bradykinin 1-7 were selected. A reversed phase-mode liquid chromatography triple quadrupole-mass spectrometry analytical method was developed, investigating the influence of the elution gradient slope of the mobile phase organic component and chromatographic column temperature influence, over the method selectivity a. This two studied components proved to be critical in respect with method selectivity and analytes separations. As a step forward, a fast and simple sample preparation method was developed for the analysis of the three peptides in human urine, overall sample preparation-liquid chromatographic-QQQ method complying with general bioanalytical validation parameters and thresholds.
引用
收藏
页码:435 / 442
页数:8
相关论文
共 50 条
  • [41] LC-MS/MS Detection of Central Carbon Metabolism using the Collision Fragments Method
    Rui, Bin
    Wen, Han
    Wang, Yongkang
    Wang, Wenfeng
    Zhang, Chen
    Zhang, Kuanchao
    Fan, Yadong
    Xie, Yifan
    Zhang, Hongxian
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2015, 9 : 115 - 122
  • [42] THERMOSPRAY LC-MS OF LARGE MOLECULES
    VESTAL, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1983, 185 (MAR): : 17 - ANYL
  • [43] Bioanalytical approaches to analyzing peptides and proteins by LC-MS/MS
    Ewles, Matthew
    Goodwin, Lee
    BIOANALYSIS, 2011, 3 (12) : 1379 - 1397
  • [44] Amino Acid Analysis of Peptides Using Isobaric-Tagged Isotope Dilution LC-MS/MS
    Woolfitt, Adrian R.
    Solano, Maria I.
    Williams, Tracie L.
    Pirkle, James L.
    Barr, John R.
    ANALYTICAL CHEMISTRY, 2009, 81 (10) : 3979 - 3985
  • [45] METABOLITE PROFILING OF MZ IN MOUSE, RAT AND HUMAN URINE BY LC-MS AND LC-MS/MS
    Li, Li
    Tian, Dandan
    Li, Chuan
    DRUG METABOLISM REVIEWS, 2008, 40 : 135 - 135
  • [46] Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA
    Millet, Aurelien
    Khoudour, Nihel
    Bros, Pauline
    Lebert, Dorothee
    Picard, Guillaume
    Machon, Christelle
    Goldwasser, Francois
    Blanchet, Benoit
    Guitton, Jerome
    TALANTA, 2021, 224
  • [47] Two new routes to perbromate formation and analysis by LC-MS/MS
    Pisarenko, Alexey N.
    Mawhinney, Douglas B.
    Young, Robert B.
    Quinones, Oscar
    Vanderford, Brett J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [48] Quantitation of thiorphan in human plasma using LC-MS/MS and its application to a bioequivalence study
    Said, Rana
    Arafat, Basel
    Arafat, Tawfiq
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2024, 1243
  • [49] Quantification of Lumefantrine in Human Plasma Using LC-MS/MS and Its Application to a Bioequivalence Study
    Pingale, Satish G.
    Mangaonkar, K. V.
    JOURNAL OF PHARMACEUTICS, 2013, 2013
  • [50] Simultaneous Determination of Ripretinib and Its Desmethyl Metabolite in Human Plasma Using LC-MS/MS
    Qian, Zhou-Yi
    Wang, Ping
    Wang, Zi-Yi
    Zhao, Yang
    Du, Tian-Tian
    Xu, Hao
    Wang, Yong-Qing
    Sun, Lu-Ning
    THERAPEUTIC DRUG MONITORING, 2024, 46 (06) : 771 - 777